Abstract: We analyzed the earnings revision of MSCI China index component stocks for October 2026. The index's 2026E EPS fell 0.99% month on month to ¥6.279 from ¥6.342, with 153 stocks revised up versus 280 revised down, as the index itself declined 7.3%, from 72.31 to 67.02. PING AN and CHINA LIFE led the negative EPS impact, with PING AN's EPS cut 15.0% (contributing -¥0.035 to index EPS) and CHINA LIFE's EPS cut 8.3% (-¥0.020), while CCB offset some of the decline with a 0.5% EPS increase (+¥0.011). TENCENT and BYD also weighed on the index, with EPS down 1.4% and 5.9% respectively. Among individual movers, Legend Biotech posted the largest EPS increase at +2,762%, followed by LONGFOR at +164% and XTALPI at +113%, while CICT Mobile Communication Technology saw the steepest EPS decline at -100.00%, followed by Tigermed at -63.2%.
CICT MOBILE COMMUNICATION TECHNOLOGY, MUYUAN FOODS, XTALPI, Tigermed, BEIJING ENLIGHT MEDIA, SICHUAN HUAFENG TECHNOLOGY
Interested in the full report? Get in touch with our team.
We will review your request. Once approved, the report will be sent to your company email.
Thank you! We will review your request and email the report to you, usually within 1 business day.